RESUMENIntroducción: La enfermedad cardiovascular afecta a la dimensión física, social y emocional del paciente y es la principal causa de muerte en el mundo. Por ello, es fundamental valorar los factores terapéuticos grupales en las sesiones de fisioterapia en los programas de rehabilitación cardiaca.Objetivos: Conocer la evolución de los pacientes coronarios tras participar en las sesiones grupales de fisioterapia de un programa de rehabilitación cardiaca y compararla con la evolución del grupo de enfermos coronarios que no participan en un programa de rehabilitación cardiaca.Metodología: Estudio longitudinal, descriptivo, y comparativo con un diseño cuasi-experimental (pre-post con grupo control), para medir el cambio de 65 enfermos coronarios que han realizado un programa de rehabilitación cardiaca con sesiones grupales de fisioterapia, en comparación con el grupo control formado por 47 sujetos.Resultados: Mejora significativa en la auto-percepción del bienestar psicológico, la calidad de vida y el estado de salud de los sujetos del grupo experimental en comparación con el grupo control.Conclusiones: Los factores terapéuticos grupales en las sesiones de fisioterapia de un programa de rehabilitación cardiaca garantizan una rehabilitación integral y promueve una adecuada calidad de vida.Palabras clave: rehabilitación cardiaca, factores terapéuticos grupales, bienestar psicológico y calidad de vida.SUMMARY Introduction: Cardiovascular disease is the leading cause of death worldwide and it affects patients physically, socially and emotionally. Therefore, it is essential to assess the impact of therapeutic group factors in physiotherapy sessions in cardiac rehabilitation programs. Objectives: To follow the evolution of coronary patients after participating in physiotherapy group sessions of a cardiac rehabilitation program and to compare it with the evolution of a group of coronary patients who do not participate in any cardiac rehabilitation program. Methodology: Longitudinal, descriptive, and comparative study with a quasi-experimental design (pre-post with control group), to assesses the change of 65 coronary patients who underwent a cardiac rehabilitation program with physiotherapy group sessions, compared to Control group composed of 47 subjects. Results: Significant improvement in self-perception of psychological well-being, quality of life and health status of subjects in the experimental group were found compared to the control group. Conclusions: Group therapeutic factors in the physiotherapy sessions of a cardiac rehabilitation program guarantee a comprehensive rehabilitation and promote an adequate quality of life. Keywords: cardiac rehabilitation, group therapeutic factors, psychological well-being and quality of life.REFERENCIAS BIBLIOGRÁFICAS.1. Medrano MJ, Pastor-Barriuso R, Boix R, del Barrio JL, Damián J, Álvarez R, et al. Riesgo coronario atribuible a los factores de riesgo cardiovascular en población española. Revista española de cardiología 2007;60(12):1250-1256.2. Achury D, Rodríguez-Colmenares SM, Agudelo-Contreras LA, Hoyos-Segura JR, Acuña-Español JA. Calidad de vida del paciente con enfermedad cardiovascular que asiste al programa de rehabilitación cardiaca. Investig Enferm Imagen Desarr 2011;13(2):49-74.3. Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, et al. Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012). 2012.4. Heran BS, Chen J, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;7(7).5. Rauch B, Riemer T, Schwaab B, Schneider S, Diller F, Gohlke H, et al. Short-term comprehensive cardiac rehabilitation after AMI is associated with reduced 1-year mortality: results from the OMEGA study. Eur J Prev Cardiol 2014 Sep;21(9):1060-1069.6. Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010 Feb;17(1):1-17.7. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011;58(23):2432-2446.8. DE D. CONSENSO EXTREMEÑO SOBRE RIESGO CARDIOVASCULAR. 9. Félix-Redondo FJ, Fernández-Bergés D, Pérez JF, Zaro MJ, García A, Lozano L, et al. Prevalencia, detección, tratamiento y grado de control de los factores de riesgo cardiovascular en la población de Extremadura (España). Estudio HERMEX. Atención primaria 2011;43(8):426-434.10. Grau M, Elosua R, de Leon AC, Guembe MJ, Baena-Díez JM, Alonso TV, et al. Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Revista Española de Cardiología 2011;64(4):295-304.11. Reid J, Ski CF, Thompson DR. Psychological interventions for patients with coronary heart disease and their partners: a systematic review. PloS one 2013;8(9):e73459.12. Bigger JT, Glassman AH. The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. Cleve Clin J Med 2010;77(suppl 3):S12-S19.13. Dickens C, Cherrington A, Adeyemi I, Roughley K, Bower P, Garrett C, et al. Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and meta-regression. Psychosom Med 2013 Feb;75(2):211-221.14. Balady GJ, Ades PA, Comoss P, Limacher M, Pina IL, Southard D, et al. Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. Circulation 2000 Aug 29;102(9):1069-1073.15. Miranda, Regina Coeli Vasques de, Padulla SAT, Bortolatto CR. Respiratory physiotherapy and its application in preoperative period of cardiac surgery. Revista Brasileira de Cirurgia Cardiovascular 2011;26(4):647-652.16. Fernández-Abascal EG, Díaz MDM, Sánchez FJD. Factores de riesgo e intervenciones psicológicas eficaces en los trastornos cardiovasculares. Psicothema 2003;15(4):615-630.17. Gaziano JM. Global burden of cardiovascular disease. Braunwald's Heart Disease.7th ed.Philadelphia: Elsevier Saunders 2005:423-455.18. Rauch B, Riemer T, Schwaab B, Schneider S, Diller F, Gohlke H, et al. Short-term comprehensive cardiac rehabilitation after AMI is associated with reduced 1-year mortality: results from the OMEGA study. Eur J Prev Cardiol 2014 Sep;21(9):1060-1069.19. Villar F, Rodríguez¬‐Artalejo F, Banegas J. Epidemiología y prevención de las enfermedades cardiovasculares. In: Hernández-¬‐Aguado I, Gil A, Delgado M, Bolúmar F, Benavides FG, Porta M, Álvarez-¬‐ Dardet C, Vioque J, Lumbreras B., editor. Manual de Epidemiología y Salud Pública. 2ª ed. ed. Madrid: Editorial Médica Panamericana; 2011. p. 155.20. Alwan A, Armstrong T, Bettcher D, Boerma T, Branca F, Ho J, et al. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization 2011.21. Wielgosz AT, Nolan RP. Biobehavioral factors in the context of ischemic cardiovascular diseases. J Psychosom Res 2000;48(4):339-345.22. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 2001;80(2):213-219.23. Beaglehole R. International trends in coronary heart disease mortality morbidity and risk factors. Epidemiol Rev 1990;12:1-15.24. Alwan A. Global status report on noncommunicable diseases 2010. : World Health Organization; 2011.25. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos med 2006;3(11):e442.26. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, et al. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis. 2012. Cerebrovasc Dis 2012;25:457-507.27. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009 Jun;16(3):333-350.28. Instituto Nacional de Estadística. Defunciones según la causa de muerte: Año 2012. 2014.29. Moreu-Burgos J, Macaya-Miguel C. Fisiopatología del miocardio isquémico. Importancia de la frecuencia cardiaca. Revista Española de Cardiología Suplementos 2007;7(4):19D-25D.30. Aguiar-Souto P, González-Juanatey JR. Angina crónica estable: fisiopatología y formas de manifestación clínica. Revista española de cardiología suplementos 2010;10:11B-21B.31. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003 Oct 7;108(14):1664-1672.32. Thygesen K, Alpert JS, Jaffe AS, White HD, Simoons ML, Chaitman BR, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60(16):1581-1598.33. World Health Organization. Constitución. 1985.34. Espinosa Caliani JS, Bravo Navas JC. Rehabilitación cardíaca y atención primaria. Madrid, España: Editorial Médica Panamericana 2002.35. Badia X, Baró MS, Alonso J. La medida de la salud: Guía de escalas de medición en español. : Tecnología y Ediciones del Conocimiento; 2002.36. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2005 Jan 25;111(3):369-376.37. Gielen S, Landmesser U. The Year in Cardiology 2013: cardiovascular disease prevention. Eur Heart J 2014 Feb;35(5):307-312.38. Ryden L, Martin J, Volqvartz S. The European Heart Health Charter: towards a healthier Europe. Eur J Cardiovasc Prev Rehabil 2007 Jun;14(3):355-356.39. Guijarro C, Brotons C, Camarelles F, Medrano M, Moreno J, Del Río A. Primera conferencia de prevención y promoción de la salud en la práctica clínica en España: Prevención cardiovascular. Atención Primaria 2008;40:473-474.40. Rodríguez Domínguez L, Herrera Gómez V, Dorta Morejón E. Algunos factores de riesgo que favorecen la aparición del infarto agudo del miocardio. Revista Cubana de Medicina General Integral 1998;14(3):243-249.41. RELACIONADO VC. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. 2013.42. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311(5):507-520.43. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010 Jan;33 Suppl 1:S62-9.44. Banegas JR, Villar F, Graciani A, Rodríguez-Artalejo F. Epidemiología de las enfermedades cardiovasculares en España. Revista Española de Cardiología Suplementos 2006;6(7):3G-12G.45. Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, et al. Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE. Revista Española de Cardiología 2008;61(10):1030-1040.46. Williams R. Patterns of reactivity and stress; Handbook of stress, reactivity, and cardiovascular disease (KA Matthews, SM Weiss, T. Detre, TM Demobroski, B. Falkner, SB Manuck, RB Williams Eds.). 1986.47. Nafziger AN, Herrington DM, Bush TL. Dehydroepiandrosterone and dehydroepiandrosterone sulfate: their relation to cardiovascular disease. Epidemiol Rev 1991;13:267-293.48. Clarkson T, Manuck S, Kaplan J. Potential role of cardiovascular reactivity in atherogenesis. Handbook of stress, reactivity, and cardiovascular disease 1986:35-47.49. Sebregts E, Falger P, Bär F. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. J Psychosom Res 2000;48(4):425-441.50. Reiner Ž. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pharmacol 2010;24(1):19-28.51. Luft FC. Workshop: mechanisms and cardiovascular damage in hypertension. Hypertension 2001 Feb;37(2 Pt 2):594-598.52. Whelton PK. Epidemiology of hypertension. The lancet 1994;344(8915):101-106.53. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J 1988;116(1):266-272.54. Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham study. CHEST Journal 1969;56(1):43-52.55. Chalmers J. The 1999 WHO-ISH Guidelines for the Management of Hypertension. Med J Aust 1999 Nov 1;171(9):458-459.56. Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, et al. Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE. Revista Española de Cardiología 2008;61(10):1030-1040.57. Banegas JR, Villar F, Graciani A, Rodríguez-Artalejo F. Epidemiología de las enfermedades cardiovasculares en España. Revista Española de Cardiología Suplementos 2006;6(7):3G-12G.58. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009;18(6):308-347.59. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998 Apr 4;316(7137):1043-1047.60. Oates JA, Wood AJ, Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319(20):1318-1330.61. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 1967;20(7):511-524.62. [Protection mechanism or risk factor. How much anxiety can the heart stand?]. MMW Fortschr Med 2004 Dec 9;146(50):18.63. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2003;4.64. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008;2(2).65. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007;1.66. Geneva W, Haslam D, James W. Report of a WHO Consultation.: Obesity. Lancet 2005;366:1197-1209.67. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983 May;67(5):968-977.68. Gómez-Doblas JJ, Muñiz J, Martin JJA, Rodríguez-Roca G, Lobos JM, Awamleh P, et al. Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE. Revista Española de Cardiología 2014;67(4):259-269.69. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on US life expectancy. N Engl J Med 2009;361(23):2252-2260.70. Freiberg MS, Pencina MJ, D'agostino RB, Lanier K, Wilson PW, Vasan RS. BMI vs. waist circumference for identifying vascular risk. Obesity 2008;16(2):463-469.71. World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity, Geneva, 3-5 June 1997. 1998.72. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet 2009;373(9669):1083-1096.73. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze M, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359(20):2105-2120.74. Vuori I. Physical activity and cardiovascular disease prevention in Europe: an update. Kineziologija 2010;42(1):5-15.75. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002 Nov;16(11):761-770.76. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344(1):3-10.77. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006 Oct;136(10):2588-2593.78. Opie LH, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 2007 Jul;28(14):1683-1693.79. Schonfeld G. Plant sterols in atherosclerosis prevention. Am J Clin Nutr 2010 Jul;92(1):3-4.80. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010 Nov;92(5):1189-1196.81. Blair SN, Horton E, Leon AS, Lee IM, Drinkwater BL, Dishman RK, et al. Physical activity, nutrition, and chronic disease. Med Sci Sports Exerc 1996 Mar;28(3):335-349.82. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990 Oct;132(4):612-628.83. Sebregts E, Falger P, Bär F. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. J Psychosom Res 2000;48(4):425-441.84. Powell KE, Blair SN. The public health burdens of sedentary living habits: theoretical but realistic estimates. Med Sci Sports Exerc 1994 Jul;26(7):851-856.85. Moriyama K, Sasaki J, Takada Y, Matsunaga A, Fukui J, Albers JJ, et al. A cysteine-containing truncated apo A-I variant associated with HDL deficiency. Arterioscler Thromb Vasc Biol 1996 Dec;16(12):1416-1423.86. Kugler J, Seelbach H, Krüskemper G. Effects of rehabilitation exercise programmes on anxiety and depression in coronary patients: A meta‐analysis. British Journal of Clinical Psychology 1994;33(3):401-410.87. Heran BS, Chen J, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;7(7).88. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004 Mar 23;109(11):1371-1378.89. Franklin BA, Bonzheim K, Gordon S, Timmis GC. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up. CHEST Journal 1998;114(3):902-906.90. López Moya B, Escolar Gutiérrez MC, Carcedo Robles C, de Pablo Zarzosa C, Portero García. R, Portabales Barreiro L. Niveles de hostilidad en pacientes con cardiopatías antes y despues del tratamiento en un programa de rehabilitación cardiaca. Revista Española de Cardiología 2014;67(1):939.91. Low CA, Thurston RC, Matthews KA. Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med 2010 Nov;72(9):842-854.92. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78(6):613-617.93. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996 Dec 15;94(12):3123-3129.94. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang N, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158(13):1422-1426.95. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996 Jun 1;93(11):1976-1980.96. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014 Mar 25;129(12):1350-1369.97. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression witk reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76(8):562-564.98. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78(6):613-617.99. Lespérance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58(2):99-110.100. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995 Feb 15;91(4):999-1005.101. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999;137(3):453-457.102. Lemos M, Agudelo Vélez DM. Consideraciones sobre la depresión como factor de riesgo en pacientes cardiovasculares. CES Psicología 2015;8(1):192-206.103. van Dijk SE, Pols AD, Adriaanse MC, Bosmans JE, Elders PJ, van Marwijk HW, et al. Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial. BMC Psychiatry 2013 May 7;13:128-244X-13-128.104. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004 May-Jun;66(3):305-315.105. Shanmugasegaram S, Russell KL, Kovacs AH, Stewart DE, Grace SL. Gender and sex differences in prevalence of major depression in coronary artery disease patients: A meta-analysis. Maturitas 2012;73(4):305-311.106. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33(7):2092-2197.107. Lespérance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000;48(4):379-391.108. Matthews KA. Psychological perspectives on the type A behavior pattern. Psychol Bull 1982;91(2):293.109. Meyer Friedman. Type A behavior: Its diagnosis and treatment. : Springer Science & Business Media; 1996.110. Montero JMM, De Pablo C, Artigao R, Morales M. Rehabilitación cardíaca. : Olalla; 1999.111. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: Final follow-up experience of 8 1/2 years. JAMA 1975;233(8):872-877.112. Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol 1980 Jan;111(1):37-58.113. Fernández-Abascal EG, Díaz MDM, Sánchez FJD. Factores de riesgo e intervenciones psicológicas eficaces en los trastornos cardiovasculares. Psicothema 2003;15(4):615-630.114. Behavior C. Coronary Heart Disease: A Critical Review. The Review Panel on Coronary-Prone Behavior and Coronary Heart Disease. Circulation 1981;63:1199-1215.115. Matthews KA, Glass DC, Rosenman RH, Bortner RW. Competitive drive, pattern A, and coronary heart disease: A further analysis of some data from the Western Collaborative Group Study. J Chronic Dis 1977;30(8):489-498.116. Reynoso Erazo L, Seligson I. Patrón conductual Tipo A en México: aplicación de un nuevo instrumento de evaluación. Arch.Inst.Cardiol.Méx 1997;67(5):419-427.117. Montero JMM, De Pablo C, Artigao R, Morales M. Rehabilitación cardíaca. : Olalla; 1999.118. Lane JD, White AD, Williams RB. Cardiovascular effects of mental arithmetic in Type A and Type B females. Psychophysiology 1984;21(1):39-46.119. Ganster DC, Schaubroeck J, Sime WE, Mayes BT. The nomological validity of the Type A personality among employed adults. J Appl Psychol 1991;76(1):143.120. Suls J, Wan CK. The relation between Type A behavior and chronic emotional distress: A meta-analysis. J Pers Soc Psychol 1989;57(3):503.121. Orth-Gomér K, Undén A. Type A behavior, social support, and coronary risk: interaction and significance for mortality in cardiac patients. Psychosom Med 1990;52(1):59-72.122. Cano-Vindel A. La ansiedad. Claves para vencerla.Málaga: Arguval 2002.123. Moser DK. The rust of life: impact of anxiety on cardiac patients. Am J Crit Care 2007 Jul;16(4):361-369.124. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994 Nov;90(5):2225-2229.125. Kubzansky LD, Kawachi I, Spiro A,3rd, Weiss ST, Vokonas PS, Sparrow D. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997 Feb 18;95(4):818-824.126. Mittleman MA, Maclure M, Sherwood JB, Mulry RP, Tofler GH, Jacobs SC, et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 1995 Oct 1;92(7):1720-1725.127. Niedhammer I, Goldberg M, Leclerc A, David S, Bugel I, Landre MF. Psychosocial work environment and cardiovascular risk factors in an occupational cohort in France. J Epidemiol Community Health 1998 Feb;52(2):93-100.128. Herrmann C, Brand-Driehorst S, Buss U, Rüger U. Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. J Psychosom Res 2000;48(4):455-462.129. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996;58(5):395-401.130. Katon WJ. Chest pain, cardiac disease, and panic disorder. J Clin Psychiatry 1990.131. Fleet R, Lavoie K, Beitman BD. Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res 2000;48(4):347-356.132. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994 Nov;90(5):2225-2229.133. Bueno AM. Tratamiento psicológico después del infarto de miocardio: estudios de caso. : Dykinson; 1997.134. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996;58(5):395-401.135. Grossi G, Perski A, Feleke E, Jakobson U. State anxiety predicts poor psychosocial outcome after coronary bypass surgery. Int J Behav Med 1998;5(1):1-16.136. Sandín B. Papel de las emociones negativas en el trastono cardiovascular: un análisis crítico. Revista de psicopatología y psicología clínica 2002;7(1):1-18.137. Smith TW, Allred KD, Morrison CA, Carlson SD. Cardiovascular reactivity and interpersonal influence: Active coping in a social context. J Pers Soc Psychol 1989;56(2):209.138. Richards MM, Giles MV. Warning: Parameter 1 to modMainMenuHelper:: buildXML () expected to be a reference, value given in/www/docs/sames. org. ar/public_html/libraries/joomla/cache/handler/callback. php on line 99. 139. Buitrago Malaver LA. Experiencias vividas de las mujeres en la etapa post infarto agudo de miocardio/Lived experiences of women in the after acute myocardial heart attack phase .140. Lacharity LA. The experiences of younger women with coronary artery disease. J Womens Health Gend Based 1999;8(6):773-785.141. Manuck S, Krantz D. Psychophysiologic reactivity in coronary heart disease and essential hypertension. Handbook of stress, reactivity, and cardiovascular disease 1986:11-34.142. Van Egeren LF, Sparrow AW. Laboratory stress testing to assess real-life cardiovascular reactivity. Psychosom Med 1989;51(1):1-9.143. Menkes MS, Matthews KA, Krantz DS, Lundberg U, Mead LA, Qaqish B, et al. Cardiovascular reactivity to the cold pressor test as a predictor of hypertension. Hypertension 1989 Nov;14(5):524-530.144. Corse CD, Manuck SB, Cantwell JD, Giordani B, Matthews KA. Coronary-prone behavior pattern and cardiovascular response in persons with and without coronary heart disease. Psychosom Med 1982;44(5):449-459.145. Allen MT, Sherwood A, Obrist PA, Crowell MD, Grange LA. Stability of cardiovascular reactivity to laboratory stressors: a 212 yr follow-up. J Psychosom Res 1987;31(5):639-645.146. Jennings JR, Bberg WK, Hutcheson J, Obrist P, Porges S, Turpin G. Publication guidelines for heart rate studies in man. Psychophysiology 1981;18(3):226-231.147. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005;45(5):637-651.148. Uchino BN, Garvey TS. The availability of social support reduces cardiovascular reactivity to acute psychological stress. J Behav Med 1997;20(1):15-27.149. Goldstein MG, Niaura R. Psychological factors affecting physical condition: Cardiovascular disease literature review. Psychosomatics 1992;33(2):134-145.150. Case RB, Moss AJ, Case N, McDermott M, Eberly S. Living alone after myocardial infarction: impact on prognosis. JAMA 1992;267(4):515-519.151. Medalie JH, Goldbourt U. Angina pectoris among 10,000 men: II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med 1976;60(6):910-921.152. Reed D, McGee D, Yano K, Feinleib M. Social networks and coronary heart disease among Japanese men in Hawaii. Am J Epidemiol 1983 Apr;117(4):384-396.153. Spielberger CD, Krasner SS, Solomon EP. The experience, expression, and control of anger. Individual differences, stress, and health psychology: Springer; 1988. p. 89-108.154. Davis MC, Matthews KA, McGrath CE. Hostile attitudes predict elevated vascular resistance during interpersonal stress in men and women. Psychosom Med 2000;62(1):17-25.155. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987;101(3):343.156. Matthews KA. Coronary heart disease and type A behaviors: update on and alternative to the Booth-Kewley and Friedman (1987) quantitative review. Psychol Bull 1988;104(3):373.157. Everson SA, Kauhanen J, Kaplan GA, Goldberg DE, Julkunen J, Tuomilehto J, et al. Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol 1997 Jul 15;146(2):142-152.158. Williams RB, Littman AB. Psychosocial factors: role in cardiac risk and treatment strategies. Cardiol Clin 1996;14(1):97-104.159. Marfil MNP, Santaella, Mª del Carmen Fernández, León AG, Turpin G, Castellar JV. Diferencias individuales asociadas a la respuesta cardiaca de defensa: variables psicofisiológicas y de personalidad. Psicothema 1998;10(3):609-621.160. Lipkus IM, Barefoot J. The assessment of anger and hostility. Anger, hostility, and the heart 1994:43-66.161. Julkunen J, Salonen R, Kaplan GA, Chesney MA, Salonen JT. Hostility and the progression of carotid atherosclerosis. Psychosom Med 1994;56(6):519-525.162. Sandín B. Papel de las emociones negativas en el trastono cardiovascular: un análisis crítico. Revista de psicopatología y psicología clínica 2002;7(1):1-18.163. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS,Jr, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989 Aug;80(2):234-244.164. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA 1988;260(7):945-950.165. Anderson L, Oldridge N, Thompson DR, Zwisler A, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 2016;67(1):1-12.166. Roger VL. Secondary prevention: the ongoing challenge. Rev Esp Cardiol (Engl Ed) 2011 Jan;64(1):8-9.167. de la Cuerda, Roberto Cano, Diego IMA, Martín JJA, Sánchez AM, Page JCM. Programas de rehabilitación cardiaca y calidad de vida relacionada con la salud. Situación actual. Revista Española de Cardiología 2012;65(1):72-79.168. Durán FS, Agudelo LHL. Rehabilitación en salud, 2. : Universidad de Antioquia; 2008.169. Porqueres IM, Rivera RC, Navas JB, Galán CP, Mohedo ED, Caliani JE. Rol del fisioterapeuta en el marco de la rehabilitación cardíaca. Fisioterapia 2003;25(3):170-180.170. Castiglioni A, Lacelette R. Historia de la Medicina. : Salvat Barcelona; 1941.171. Stokes W. The Diseases of the Heart and the Aorta. : Lindsay and Blakiston; 1855.172. Denolin H. La rehabilitación cardiaca. Aspectos históricos de su desarrollo. Monocardio 1990;28:8-9.173. Levine SA, Lown B. Armchair treatment of acute coronary thrombosis. J Am Med Assoc 1952;148(16):1365-1369.174. NEWMAN LB, ANDREWS MF, KOBLISH MO, BAKER LA. Physical medicine and rehabilitation in acute myocardial infarction. AMA archives of internal medicine 1952;89(4):552-561.175. Cain HD, Frasher WG, Stivelman R. Graded activity program for safe return to self-care after myocardial infarction: Electrocardiographic monitoring of the patient's response to activity is the most reliable procedure for early detection of coronary insufficiency. JAMA 1961;177(2):111-115.176. Hellerstein HK, Ford AB. Rehabilitation of the cardiac patient. J Am Med Assoc 1957;164(3):225-231.177. López-Jiménez F, Pérez-Terzic C, Zeballos PC, Anchique CV, Burdiat G, González K, et al. Consenso de rehabilitación cardiovascular y prevención secundaria de las Sociedades Interamericana y Sudamericana de Cardiología. Revista Uruguaya de Cardiología 2013;28(2):189-224.178. World Health Organization. Rehabilitation of patients with cardiovascular disease: report on a seminar. 1969.179. World Health Organization. Needs and action priorities in cardiac rehabilitation and secondary prevention in patients with coronary heart disease. Geneva: WHO Regional Office for Europe 1993;6.180. Serra J. Tipos de ejercicio físico y su valoración: aplicaciones en la rehabilitación de pacientes con infarto de miocardio. Apunts Medicina de l Esport (Castellano) 1978;15(060):223-230.181. Wenger N, Froelicher E, Smith L, Ades P, Berra K, Blumenthal J, et al. Cardiac rehabilitation: clinical practice guideline No. 17. US Dept of Health and Human Services AHCPR Publication 1995(96-0672).182. Gómez-González A, Montiel-Trujillo A, Bravo-Escobar R, Garcia-Gomez O, Corrales-Márquez R, Bravo-Navas J, et al. Equipo multidisciplinario en las Unidades de Rehabilitación Cardíaca.¿ Qué papel desempeñamos? Rehabilitación 2006;40(6):290-300.183. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, et al. Guidelines on myocardial revascularization. Eur Heart J 2010 Oct;31(20):2501-2555.184. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013 Oct;34(38):2949-3003.185. Fernández P, Velasco J. Rehabilitación del paciente con infarto agudo del miocardio. Movilización precoz. Valoración funcional y estratificación del riesgo coronario. Rehabilitación del paciente cardíaco.Barcelona: Ediciones Doyma 1993:81-90.186. Maroto J, de Pablo C. Aspectos especiales de la rehabilitación después de la revascularización coronario. Rehabilitación del paciente cardíaco.Barcelona: Ediciones Doyma 1993:125-138.187. Grima-Serrano A, García-Porrero E, Luengo-Fernández E, Latre ML. Cardiología preventiva y rehabilitación cardiaca. Revista Española de Cardiología 2011;64:66-72.188. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273(5):402-407.189. Rivas-Estany E. El ejercicio físico en la prevención la rehabilitación cardiovascular. Revista Española de Cardiología Suplementos 2011;11:18-22.190. Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil 2006 Jun;13(3):369-374.191. Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol 2004;93(3):336-339.192. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004 Jun 8;109(22):2705-2711.193. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362(7):590-599.194. i Martín, Josep Miquel Sunyer. Psicoterapia de grupo grupoanalítica: la co-construcción de un conductor de grupos. : Biblioteca Nueva; 2008.195. Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013 May;75(4):335-349.196. MÆland JG, Havik OE. Psychological predictors for return to work after a myocardial infarction. J Psychosom Res 1987;31(4):471-481.197. Goulding L, Furze G, Birks Y. Randomized controlled trials of interventions to change maladaptive illness beliefs in people with coronary heart disease: systematic review. J Adv Nurs 2010;66(5):946-961.198. Leventhal H. A perceptual-motor theory of emotion. Advances in experimental social psychology 1984;17:117-182.199. Lau‐Walker M. A conceptual care model for individualized care approach in cardiac rehabilitation–combining both illness representation and self‐efficacy. British journal of health psychology 2006;11(1):103-117.200. Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychology and health 2003;18(2):141-184.201. Goulding L, Furze G, Birks Y. Randomized controlled trials of interventions to change maladaptive illness beliefs in people with coronary heart disease: systematic review. J Adv Nurs 2010;66(5):946-961.202. Goulding L, Furze G, Birks Y. Randomized controlled trials of interventions to change maladaptive illness beliefs in people with coronary heart disease: systematic review. J Adv Nurs 2010;66(5):946-961.203. Petrie KJ, Weinman J, Sharpe N, Buckley J. Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. BMJ 1996 May 11;312(7040):1191-1194.204. Dunderdale K, Thompson DR, Miles JN, Beer SF, Furze G. Quality‐of‐life measurement in chronic heart failure: do we take account of the patient perspective? European journal of heart failure 2005;7(4):572-582.205. Petrie KJ, Weinman J. Perceptions of health and illness: Current research and applications. : Taylor & Francis; 1997.206. Sandín B. Papel de las emociones negativas en el trastono cardiovascular: un análisis crítico. Revista de psicopatología y psicología clínica 2002;7(1):1-18.207. Muller-Riemenschneider F, Meinhard C, Damm K, Vauth C, Bockelbrink A, Greiner W, et al. Effectiveness of nonpharmacological secondary prevention of coronary heart disease. Eur J Cardiovasc Prev Rehabil 2010 Dec;17(6):688-700.208. Bigger JT, Glassman AH. The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. Cleve Clin J Med 2010 Jul;77(Suppl 3):S12-9.209. Thuesen L, Henriksen LB, Engby B. One-year experience with a low-fat, low-cholesterol diet in patients with coronary heart disease. Am J Clin Nutr 1986 Aug;44(2):212-219.210. Fernández-Abascal EG, Díaz MDM, Sánchez FJD. Factores de riesgo e intervenciones psicológicas eficaces en los trastornos cardiovasculares. Psicothema 2003;15(4):615-630.211. Stamler J, Farinaro E, Mojonnier LM, Hall Y, Moss D, Stamler R. Prevention and control of hypertension by nutritional-hygienic means: Long-term experience of the Chicago Coronary Prevention Evaluation Program. JAMA 1980;243(18):1819-1823.212. Chesney MA, Frautschi NM, Rosenman RH. Modifying Type A behavior. Prevention in health psychology 1985;8:130.213. Fernández-Abascal EG, Díaz MDM, Sánchez FJD. Factores de riesgo e intervenciones psicológicas eficaces en los trastornos cardiovasculares. Psicothema 2003;15(4):615-630.214. Suinn RM, Bloom LJ. Anxiety management training for pattern A behavior. J Behav Med 1978;1(1):25-35.215. Nunes EV, Frank KA, Kornfeld DS. Psychologic treatment for the type A behavior pattern and for coronary heart disease: a meta-analysis of the literature. Psychosom Med 1987;49(2):159-173.216. Reyes LC. Intervención cognitivo-conductual para la disminución del estrés en pacientes con cardiopatía isquémica. Summa Psicológica UST 2011;8(1):21-28.217. Barlow DH, Lehman CL. Advances in the psychosocial treatment of anxiety disorders: Implications for national health care. Arch Gen Psychiatry 1996;53(8):727-735.218. Suinn RM. The terrible twos—anger and anxiety: Hazardous to your health. Am Psychol 2001;56(1):27.219. Convers Rodríguez AM, Fonseca Mojica, María del Pilar. Relación entre la condición laboral actual, las estrategias de afrontamiento, el nivel de estrés y ansiedad y una medida de riesgo cardiovascular en pacientes con enfermedad coronaria 2012.220. Lacruz MG, Gómez AI. Intervención en el patrón de conducta tipo A: Un modelo interdisciplinar. Persona: Revista de la Facultad de Psicología 2004(7):71-85.221. Mayou R, Williamson B, Foster A. Attitudes and advice after myocardial infarction. Br Med J 1976 Jun 26;1(6025):1577-1579.222. Buby C, Elfner LF, May JG. Relaxation pretraining, pulse wave velocity and thermal biofeedback in the treatment of essential hypertension. International Journal of Psychophysiology 1990;9(3):225-230.223. Amigo I, Fernández A, González A, Herrera J. Relajación muscular y monitorización ambulatoria de la presión arterial en la hipertensión arterial. Psicothema 2002;14:47-52.224. Bennett P, Carroll D. Cognitive-behavioural interventions in cardiac rehabilitation. J Psychosom Res 1994;38(3):169-182.225. Thoresen CE, Friedman M, Gill JK, Ulmer DK. The recurrent coronary prevention project. Some preliminary findings. Acta Med Scand 1982;211(S660):172-192.226. Billings JH, Scherwitz LW, Sullivan R, Sparler S, Ornish DM. The Lifestyle Heart Trial: Comprehensive treatment and group support therapy. 1996.227. de Llergo, Irma Cristina Acosta López, Araiza YIS. Manifestación de la resiliencia como factor de protección en enfermos crónico terminales hospitalizados. En la Variedad está el Enriquecimiento In Diversity we find Enhancement 2009:24.228. Bloch S, Crouch E. Therapeutic factors in group psychotherapy. : Oxford University Press, USA; 1985.229. Antequera Jurado R, Borda Mas, María de las Mercedes, Vedia O, Luisa M, Blanco Picabia I. Personalidad y calidad de vida en pacientes con infarto de miocardio. Análisis y modificación de conducta 1997;23(90):455-471.230. del Pino Pérez A, Meizoso MTG. El formato unipolar de la escala de Bortner y su contribución a la mejora de las propiedades psicométricas de la misma. Qurriculum: Revista de teoría, investigación y práctica educativa 1991(1):179-186.231. Hostility and type A behavior components. Poster Pretented at the First European Conference of Psychology; 1989.232. Williams RB, Littman AB. Psychosocial factors: role in cardiac risk and treatment strategies. Cardiol Clin 1996;14(1):97-104.233. Michalsen A, Grossman P, Lehmann N, Knoblauch NT, Paul A, Moebus S, et al. Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychother Psychosom 2005;74(6):344-352.234. Espinosa Caliani S, Bravo Navas JC, Gómez-Doblas JJ, Collantes Rivera R, González Jiménez B, Martínez Lao M, et al. Rehabilitación cardiaca postinfarto de miocardio en enfermos de bajo riesgo. Resultados de un programa de coordinación entre cardiología y atención primaria. Revista Española de Cardiología 2004;57(01):53-59.